Physician profile
Steven C Sauk
NPI 1215101712
$67,776.58
in general payments reported to CMS, 2019-2025
20 companies · $21K in 2025
The $21K reported for 2025 was more than what 93% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $4,413 · 2021: $2,016 · 2022: $4,138 · 2023: $8,097 · 2024: $16K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Travel and Lodging: $3,677 · Food and Beverage: $2,454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,370.00 |
| Travel and Lodging | $3,677.16 |
| Food and Beverage | $2,454.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $47,328.60 | 2020-2025 | Venovo, Lutonix Drug Coated Balloon, Trek |
| Becton, Dickinson and Company | $12,312.14 | 2019-2025 | Pleurx |
| Cook Incorporated | $3,920.00 | 2025 | Cook, Rosch-Uchida |
| Philips North America LLC | $900.00 | 2019 | |
| Boston Scientific Corporation | $681.62 | 2022-2025 | General - Embolics, Obsidio, Embold Fibered |
| Cardiovascular Systems INC. | $394.99 | 2022 | |
| Angiodynamics, INC. | $344.77 | 2022-2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $321.96 | 2019-2023 | Supera |
| Penumbra, INC. | $251.01 | 2024 | Indigo System |
| C. R. Bard, INC. & Subsidiaries | $244.53 | 2019 | |
| Cook Medical LLC | $219.21 | 2019-2025 | Zilver Ptx, Cook, Cook Celect |
| Medtronic, INC. | $184.86 | 2022-2025 | Emprint, Concertotm |
| W. L. Gore & Associates, INC. | $150.68 | 2025 | Viatorr Endoprosthesis |
| Trisalus Life Sciences, INC. | $144.27 | 2022 | |
| Davol INC. | $141.07 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $96.85 | 2023 | S.M.A.R.T. |
| Reprise Biomedical, INC. | $71.66 | 2025 | Miro3d |
| Janssen Pharmaceuticals, INC | $30.92 | 2022 | |
| Biosense Webster, INC. | $24.47 | 2022 | |
| Argon Medical Devices, INC. | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Sauk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.